As a result of the merger between Swedish Astra AB company and UK-based Zeneca Group PLC, it is now one of the world's leading pharmaceutical companies, both in research and development, with presence in the main therapeutic areas and a strong foothold and leadership position in all five continents.
CH+B is working on executing communications that help provide identity and convey innovation and technology.
A consistent identity throughout all the formats used, that reflects AstraZeneca's prestige and provides loyalty in the healthcare industry.
Diabetes Summit was an event hosted by AstraZeneca, one of the world's leading pharmaceutical companies in research and development.
CH+B worked on designing and organizing an event that strongly contributes to the construction of a powerful and dynamic image. The formal vocabulary communicates innovation by using geometric shapes that derive from the logotype, exclusively created for the event.
The format of the event consisted of a scientific education program developed in association with a local and international expert committee, with the objective of improving clinical management with the latest treatments for type 2 diabetes and helping improve the patients' life quality.
"Challenging paradigms" was the claim that identified the event both in its conceptual and aesthetic development.